Over the past six months, journalists for the Columbus Dispatch have written more than 40 articles about the murky world of pharmacy benefit managers (PBMs) in Ohio. This week, they wrote one of the most important stories in this ongoing series, “Ohio firing pharmacy middlemen that cost taxpayers millions.”
In this article, they explained that the Ohio Department of Medicaid was changing the way it pays for prescription drugs by, “giving the boot to all pharmacy middlemen” because the Medicaid program wants to shift away from what’s called the “spread pricing” practice. Continue reading
You may have recently heard about the multimillion-dollar donation that Bill Gates and Leonard Lauder made to support research into biomarkers for early detection of Alzheimer’s disease and related dementias.
The Diagnostics Accelerator initiative is part of the Alzheimer’s Drug Discovery Foundation’s (ADDF) effort to speed diagnosis and develop drugs that can prevent, treat, and cure the disease. Lauder was an ADDF co-founder. Continue reading
In his landmark Oral Health in America report in 2000, then-Surgeon General David Satcher reminded the nation that oral health is essential to general health. Satcher hailed progress made in the scientific understanding of common oral maladies such as tooth decay.
But at the same time, Satcher warned of a “silent epidemic” of oral disease burdening millions of Americans, including poor children and seniors, minorities and those living with disabilities. Continue reading
Photo: CDCAedes aegypti
More than five million children around the world die before the age of five from infectious diseases like pneumonia, malaria and measles, and scientist John Aitchison wants to talk to journalists about his work to reverse that trend.
“We can help journalists with the significance or size of an issue and provide understanding of why a disease is hard to cure or treat,” says Aitchison, whose organization, the Center for Infectious Disease Research (CIDR) announced plans in July 2018 to merge with the Seattle Children’s Research Institute. Continue reading
When covering prescription drug pricing, one problem that journalists face is understanding the almost-labyrinthian complexity of the drug supply chain, from manufacturer to consumer.
For one of its first investigations, the young publication Tarbell set out to explain why drug prices are so high. In doing so, Tarbell Editor Randy Barrett describes in great detail the complex world of pharmacy pricing. Continue reading